TESARO Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
54.91 M |
Public Float |
16.79 M |
TESARO Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$9.84 |
Market Cap |
$1.93 B |
Shares Outstanding |
54.91 M |
Public Float |
38.27 M |
Address |
1000 Winter Street Waltham Massachusetts 02451 United States |
Employees | - |
Website | http://www.tesarobio.com |
Updated | 09/14/2018 |
TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr. |